Malaysia’s FurleyBioextracts goes to World Cup Tech Challenge finals
One of the four biotech finalists in the 3rd Annual World Cup Tech Challenge organized by Silicon Valley Forum is FurleyBioextractsSdnBhd, a wholly Malaysian owned and operated company.
The company will showcase its product, Spray 8®, to a panel of judges comprising venture capitalists, angel investors and C-suites on June 1 at Microsoft in Mountain View, California.
Should they win,FurleyBioextracts will be the first Asian company to win in any category in this challenge. The online voting portal is now live, with each valuable vote contributing towards the possible win.
Spray 8 ® is an all-natural, water-based, painless, advanced wound and skin care remedy utilizing mangosteen skin extract as its main active ingredient.
The mangosteen skin extract, DermaXan™ is derived at their cGMP (Current Good Manufacturing Practices) factory in Selangor, Malaysia. Their proprietary technology is designed to perform the extraction process using water, while maximizing active components and minimizing waste.
“We firmly believe in harnessing the incredibly nutrient diverse qualities of mangosteen, which we have been researching for 6 years”, says FurleyBioextracts Managing Director Stuart Soo.
“FurleyBioextracts policy is to create products that speak for themselves. We take pride in delivering products that are natural, effective, safe and affordable,” he adds.
While Spray 8® is already retailing in leading pharmacies in Malaysia as well as on the company website, ongoing research continues to be performed on the product.
Currently, Spray 8® is in Phase 2B of clinical trials at UniversitiTeknologi MARA (UiTM) Teaching Hospital, Sungai Buloh, Selangor. Testing parameters include safety, anti-bacterial and anti-inflammatory properties of the remedy with a multitude of applications. The different applications range from small cuts and burns to eczema, skin allergies and chronic wounds (including diabetic wounds).
